Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenetic Biosciences Inc (NASDAQ:XBIO)

2.49
Delayed Data
As of Jan 18
 +0.1987 / +8.67%
Today’s Change
1.75
Today|||52-Week Range
5.90
+29.79%
Year-to-Date
No recent news for Xenetic Biosciences Inc.

Today’s Trading

Previous close2.29
Today’s open2.66
Day’s range2.21 - 3.18
Volume90,634
Average volume (3 months)23,854
Market cap$20.0M
Data as of 3:57pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)-163.97%
Earnings growth (this year)+88.65%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales10.65
Price/Book1.19

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...+0.10+3.73%
AOXGAoxing Pharmaceutica...-0.01-13.33%
HTBXHeat Biologics Inc-0.01-2.98%
DAREDare Bioscience Inc-0.03-1.32%
Data as of 4:00pm ET, 01/18/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$3.0M
Annual profit (last year)-$54.2M
Net profit margin-1,806.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Director, Chief Executive &
Operating Officer
Jeffrey F. Eisenberg
Secretary, Chief Financial &
Accounting Officer
James F. Parslow
Corporate headquarters
Lexington, Massachusetts

Forecasts